Search in:

ClinicoEconomics and Outcomes Research Volume 11, 2019 - Issue

Submit an article Journal homepage

Open access

112

Views

CrossRef citations to date

Altmetric

Original Research

A Cost-Effectiveness Analysis Of An Adenocarcinoma Risk Prediction Multi-Biomarker Assay For Patients With Barrett’s Esophagus

Jing Hao1 Department of Epidemiology and Health Services Research, Geisinger, Danville, PA, USACorrespondence[email protected]

Rebecca Critchley-Thorne2 Research & Development, Cernostics Inc, Pittsburgh, PA, USA

David L Diehl3 Department of Gastroenterology, Geisinger, Danville, PA, USA

Susan R Snyder1 Department of Epidemiology and Health Services Research, Geisinger, Danville, PA, USA

https://orcid.org/0000-0002-2802-144X

Pages 623-635 | Published online: 25 Oct 2019

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (11)

Won-Tak Choi, Gregory Y. Lauwers & Elizabeth A. Montgomery. (2022) Utility of ancillary studies in the diagnosis and risk assessment of Barrett's esophagus and dysplasia. Modern Pathology 35:8, pages 1000-1012.
Crossref

Nurul Hidayah & Yuna Annisa Salsabila. (2022) Cellulose Sponge, the Detector of Esophageal Cancer: Innovation for Early Detection of Esophageal Cancer without Biopsy?: A Mini Review. Open Access Macedonian Journal of Medical Sciences 10:F, pages 386-390.
Crossref

Nicholas J. ShaheenGary W. FalkPrasad G. IyerRhonda F. SouzaRena H. YadlapatiBryan G. SauerSachin Wani. (2022) Diagnosis and Management of Barrett's Esophagus: An Updated ACG Guideline. American Journal of Gastroenterology 117:4, pages 559-587.
Crossref

Ravi Vissapragada, Norma B. Bulamu, Christine Brumfitt, Jonathan Karnon, Roger Yazbeck & David I. Watson. (2021) Improving cost-effectiveness of endoscopic surveillance for Barrett’s esophagus by reducing low-value care: a review of economic evaluations. Surgical Endoscopy 35:11, pages 5905-5917.
Crossref

Nicola F. Frei, Amir M. Khoshiwal, Kadere Konte, Emily A. Bossart, Katelyn Stebbins, Yi Zhang, Roos E. Pouw, Fiebo J.W. ten Kate, Kees A. Seldenrijk, Sybren L. Meijer, Rebecca J. Critchley-Thorne & Jacques J.G.H.M. Bergman. (2021) Tissue Systems Pathology Test Objectively Risk Stratifies Barrett's Esophagus Patients With Low-Grade Dysplasia. American Journal of Gastroenterology 116:4, pages 675-682.
Crossref

David L. Diehl, Harshit S. Khara, Nasir Akhtar & Rebecca J. Critchley-Thorne. (2021) TissueCypher Barrett’s esophagus assay impacts clinical decisions in the management of patients with Barrett’s esophagus. Endoscopy International Open 09:03, pages E348-E355.
Crossref

Rhonda F. Souza & Stuart Jon Spechler. (2021) Advances in Biomarkers for Risk Stratification in Barrett’s Esophagus. Gastrointestinal Endoscopy Clinics of North America 31:1, pages 105-115.
Crossref

Joel H. Rubenstein & John M. Inadomi. (2021) Cost-Effectiveness of Screening, Surveillance, and Endoscopic Eradication Therapies for Managing the Burden of Esophageal Adenocarcinoma. Gastrointestinal Endoscopy Clinics of North America 31:1, pages 77-90.
Crossref

Michael B. Cook & Aaron P. Thrift. (2021) Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma. Gastrointestinal Endoscopy Clinics of North America 31:1, pages 1-26.
Crossref

Jon M. Davison, John Goldblum, Udhayvir Singh Grewal, Kevin McGrath, Kenneth Fasanella, Christopher Deitrick, Aaron D. DeWard, Emily A. Bossart, Stephen L. Hayward, Yi Zhang, Rebecca J. Critchley-Thorne & Prashanthi N. Thota. (2020) Independent Blinded Validation of a Tissue Systems Pathology Test to Predict Progression in Patients With Barrett's Esophagus. American Journal of Gastroenterology 115:6, pages 843-852.
Crossref

Nicola F. Frei, Kadère Konte, Emily A. Bossart, Katelyn Stebbins, Yi Zhang, Roos E. Pouw, Rebecca J. Critchley-Thorne & Jacques J.G.H.M. Bergman. (2020) Independent Validation of a Tissue Systems Pathology Assay to Predict Future Progression in Nondysplastic Barrett's Esophagus: A Spatial-Temporal Analysis. Clinical and Translational Gastroenterology 11:10, pages e00244.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

A Cost-Effectiveness Analysis Of An Adenocarcinoma Risk Prediction Multi-Biomarker Assay For Patients With Barrett’s Esophagus

Articles from other publishers (11)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

A Cost-Effectiveness Analysis Of An Adenocarcinoma Risk Prediction Multi-Biomarker Assay For Patients With Barrett’s Esophagus

Citations (11)

Articles from other publishers (11)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date